AKT1 and neoplasm: Given that PD-1 blockade can restore T cell function and reduce tumor-intrinsic AKT signaling 25, the observed decrease in pAKT likely reflects a dual effect of enhanced antitumor immunity and suppression of tumor cell survival signaling in BRCA1-deficient tumors.